Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastrointest Oncol. Apr 15, 2021; 13(4): 265-278
Published online Apr 15, 2021. doi: 10.4251/wjgo.v13.i4.265
Table 2 Expression profiles of primary gastric cancer and remnant gastric cancer patients

Primary GC
Remnant GC

Variables
n 284 (%)
n 40 (%)
P value
EBV0.039a
Negative254 (89.4)31 (77.5)
Positive30 (10.6)9 (22.5)
MSI/MSS status0.362
MSS224 (78.9)29 (72.5)
MSI60 (21.1)11 (27.5)
p530.121
Normal177 (62.8)20 (50)
Aberrant105 (37.2)20 (50)
E-cadherin0.565
Normal255 90.7)35 (87.5)
Loss of expression26 (9.3)5 (12.5)
Profiles with altered expression (EBV, MSI, E-cadherin, p53)< 0.001a
One or none261 (91.9)26 (65)
Two or more23 (8.1)14 (35)
Number of altered profiles-
086 (30.3)13 (32.5)
1175 (61.6)13 (32.5)
223 (8.1)11 (27.5)
30 (0)2 (5)
40 (0)1 (2.5)